Voyageur Pharmaceuticals (CVE:VM) Sets New 52-Week Low – Here’s What Happened

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) shares hit a new 52-week low on Tuesday . The stock traded as low as C$0.09 and last traded at C$0.10, with a volume of 37646 shares changing hands. The stock had previously closed at C$0.10.

Voyageur Pharmaceuticals Stock Down 5.0%

The company has a 50 day moving average of C$0.12 and a 200-day moving average of C$0.15. The company has a market capitalization of C$17.05 million, a P/E ratio of -9.50 and a beta of 1.07. The company has a debt-to-equity ratio of 6.05, a current ratio of 0.18 and a quick ratio of 0.84.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.

Featured Articles

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.